登录 注册 会员服务 联系我们

Gender Differences in Hematological Toxicity among Patients with Non-small Cell Lung Cancer Given a Combination of Platinating Agent and Gemcitabine

  • Published:2012 Issue:7 Volume:38 Page:441-448
  • ISSN:1346-342X
  • Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
  • language:en
  • Short-container-title:Jpn. J. Pharm. Health Care Sci.

Author:

Keira Takayuki,Mita Kyouhei,Kojima Masateru,Sekido Kanae,Hishinuma Ryuichi,Tanaka Tsuneaki

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference11 articles.

1. 1）Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, Katagami N, Ariyoshi Y, Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesin, and cisplatine in unresectable stage Ⅲ non-small-cell lung cancer, J Clin Oncol, 1999, 17, 2692-2699.

2. 2）Alberti W, Anderson G, Bartolucci A, Bell D, Blanco JV, Brodin O, Cardiello C, Cartei F, Cartei G, Cellerino R, Chastang C, Cormier Y, Cox JD, Crino L, Crowley J, Dautzenberg B, Depierre A, Dietemann A, Dillman RO, Doi O, Feld R, Figlin R, Ganz PA, Green MR, Gregor A, Helle PA, Herndon JE, Hitomi S, Host H, Imaizumi M, Jett JR, Johnson D, Kaasa S, Kimura H, Klastersky J, Kondo H, Kreisman H, Kris MG, Kunishima K, Kuwahara O, Lad TE, Laing AH, Macbeth F, Masaoka A, Mattson K, Minatel E, Mira JG, Mori T, Mountain CF, Niederle N, Niiranen A, Nou E, Page W, Pater J, Piantadosi S, Pisters KMW, Pyrhonen S, Quoix E, Rapp E, Rowell NP, Sahmoud T, Sawamura K, Schallier DC, Scott C, Simpson J, Stagg M, Teramatsu T, Trovo MG, Tsuchiya R, Tummarello D, Houtte PV, Zandwijk NV, Vincent RG, Wada H, White JE, Williams CJ, Woods RL, Yamaguchi Y, Non-small Cell Lung Cancer Collaborative Group, Chemotherapy in nonsmall cell lung cancer: a meta-analysis using update data on individual patients from 52 randomised clinical trials, BMJ, 1995, 311, 899-909.

3. 3）Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH, Comparison of four chemotherapy regimens for advanced non-small-cell-lung cancer, N Eng J Med, 2002, 346, 92-98.

4. 4）Zatloukal P, Petruzelka L, Zemanova M, Kolek V, Skrickova J, Pesek M, Fojtu H, Grygarkova I, Sixtova D, Roubec J, Horenkova E, Havel L, Prusa P, Novakova L, Skacel T, Kuta M, Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage Ⅲb and Ⅳ non-small cell lung cancer: a phase Ⅲ randomized trial, Lung Cancer, 2003, 41, 321-331.

5. 5）Thatcher N, Chang A, Parikh P, Pereira JR, Ciuleanu T, Pawel J, Thongprasert S, Tan EH, Pemberton K, Archer V, Carroll K, Gefetinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomaised, placebo-controlled, multicentre study（Iressa Survival Evaluation in Lung Cancer）, Lancet, 2005, 366, 1527-1537.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3